Basilea Pharmaceutica’s CHF 45.75 Million Shares Offering

Baker McKenzie advised Basilea Pharmaceutica Ltd. on all legal aspects of this PIPE transaction. Homburger advised the managers.Basilea Pharmaceutica Ltd. successfully completed a capital increase from authorized…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here